Zynerba Pharmaceuticals Stock Price

0.24 (4.43%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Zynerba Pharmaceuticals Inc ZYNE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.24 4.43% 5.66 20:00:00
Open Price Low Price High Price Close Price Prev Close
5.45 5.43 5.86 5.64 5.42
Bid Price Ask Price Spread News
5.50 5.71 0.21 1 1
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10,829 2,029,462 $ 5.60 $ 11,368,137 1,733,062 2.80 - 9.00
Last Trade Time Type Quantity Stock Price Currency
19:59:00 30 $ 5.67 USD

Zynerba Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 233.48M 41.25M 39.99M $ - $ - -1.93 -3.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 5.90%

more financials information »

Zynerba Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZYNE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.18525.865.045.461,598,6820.47489.16%
1 Month4.355.864.255.181,875,3991.3130.11%
3 Months4.925.863.684.691,602,8490.7415.04%
6 Months4.,480,0821.5838.73%
1 Year5.039.002.804.922,222,2730.6312.52%
3 Years11.2316.472.556.571,390,441-5.57-49.6%
5 Years8.7025.952.557.631,010,643-3.04-34.94%

Zynerba Pharmaceuticals Description

Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system.

Your Recent History
Zynerba Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.